Eli Lilly to Buy Cancer Drug Specialists Loxo Oncology
In the second major pharmaceutical deal of the year, Eli Lilly will pay about $8 billion for Loxo Oncology.
Bristol-Myers to Buy Big Pharma Rival Celgene
The $74 billion deal could create the fourth-largest U.S. pharma firm, with a portfolio that includes nine blockbuster drugs.
New Products Fuel Eli Lilly Q1 Earnings Beat
Drugs such as the diabetes treatment Trulicity "led the company to a strong quarter of volume-driven revenue growth."
Bayer Discloses $62B Offer for Monsanto
The deal would create the world's largest agricultural supplier but Bayer shareholders fear it will be detrimental to its pharmaceutical business
Mylan to Pay 92% Premium for Sweden’s Meda
After a relentless pursuit, pharmaceutical firm Mylan pays a large premium to acquire a company that sells over-the-counter drugs.